<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Drugs & Industries Ltd has filed an initial disclosure with BSE confirming its status under SEBI's Large Corporate framework (related to fund raising through debt securities). The company has confirmed that it is 'Not a Large Corporate' as of 31st March 2025, based on the applicability criteria under SEBI Circular dated November 26, 2018 and October 19, 2023. Consequently, no further disclosures are required for the financial year 2024-25.
This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms the company falls below the SEBI 'Large Corporate' threshold, meaning it has reduced mandatory disclosure and borrowing obligations.